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Objectives. The aim of this study was to assess the relation
between operator experience in coronary stent placement proce-
dures and the clinical outcome of patients.
Background. The results of coronary balloon angioplasty are
closely related to the experience of the operator performing the
procedure. Data on the effect of operator experience on the results
after coronary stent placement are missing.
Methods. The study included 3,409 consecutive patients under-
going coronary stent placement for the management of coronary
artery disease. A composite end point of cardiac death, myocardial
infarction and aortocoronary bypass surgery during the first 30
days after the intervention, was the primary end point and the
procedural failure was the secondary end point of the study.
Results. Adverse clinical outcome occurred in 2.99% of the
3,409 patients undergoing coronary stent placement. Procedural
failure was recorded in 2.08% of the patients. Operator volumes
above 483 procedures were associated with a risk-adjusted ad-
verse outcome rate of 1.70% 6 1.28%, which is significantly lower
than the overall rate of 2.99%. Operator yearly volumes of under
90 procedures were associated with a risk-adjusted adverse out-
come rate of 4.59% 6 1.17%, which is significantly higher than the
overall rate of 2.99%. The operator experience was an independent
predictor even after adjusting for the effect of other risk factors.
The analysis demonstrated that an experience of at least 100
procedures is required to obtain better outcome even in patients
with simple coronary lesions and that operators should perform at
least 70 procedures annually to expect a better outcome in
patients with both simple and complex coronary lesions.
Conclusions. Operator experience is a significant and indepen-
dent predictor of the outcome of patients undergoing coronary
stent placement. An experience of at least 100 procedures and an
annual volume of at least 70 procedures are required to ensure a
significantly better outcome after coronary stent implantation.
(J Am Coll Cardiol 1998;32:970–6)
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A significant correlation has been demonstrated between
operator and/or institution experience and outcome after
aortocoronary bypass surgery (CABG) (1,2) or percutaneous
transluminal coronary angioplasty (PTCA) (3–9). This has
frequently been viewed as a confirmation of the old paradigm
that “practice makes perfect” (10–14) and has served as the
rationale for initiating the public release of operator-specific
data about cardiovascular procedures and advocating the use
of “scorecards” (15,16) or practice profiles of individual oper-
ators (17). The relationship between experience and outcome
has been the basis for establishing volume standards to be met
by hospitals and single operators before granting clinical
privileges in PTCA (18–20). Coronary stent placement is an
established treatment option for symptomatic coronary artery
disease (21–24). It is increasingly used in most centers and
frequently constitutes more than 60% of the total number of
coronary interventions (25,26). Stent implantation is some-
times considered as a “great leveler” of physician expertise in
coronary interventions (13) because it may prevent the early
complications in bailout situations after PTCA (27,28). How-
ever, data about the relationship between experience and
outcome for coronary stent placement are not available and,
accordingly, no recommendations about the required volume
of procedures for sufficient expertise have been formulated
(26,29). It has been pointed out that assessment of the value of
strategies of medical care, including the value provided by
individual practitioners, has become a reality which requires
the development of efficient and fair methods of assessment
(30).
The primary objective of the study was to assess the relation
between operator experience in coronary stent placement
procedures and early (30-day) clinical outcome of the patients.
As a secondary objective, the relation between operator expe-
rience and procedural success was also assessed.
Methods
Patient population. The study population consisted of all
3,409 patients with symptomatic coronary artery disease who
underwent coronary stent placement at our institution from
May 1992 through September 1997. Excluded were only 73
patients who had been in cardiogenic shock or under mechan-
ical ventilation before stent placement procedure.
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All patients received heparin and aspirin intravenously
before the intervention. The stent implantation attempt was
always preceded by conventional balloon angioplasty. Hand-
crimped, slotted tube stents on balloons of different sizes were
used in almost all cases. Balloon size and pressure were at the
operator’s discretion. A more detailed description of the
technique has been published previously (28). All patients with
successful stent placement were given anticoagulant or anti-
platelet therapies (23) to prevent stent thrombosis.
Data collection, definitions and end points. All data were
entered into a database. The physician who performed the
intervention entered the data related to the procedure. Other
clinical, laboratory, quantitative angiographic and follow-up
data were entered by physicians not involved in the interven-
tion. Data completeness and consistency were systematically
checked by the software and by a physician in charge of
database supervision. The entered name of the operator was
checked for consistency with that on the signed report of the
intervention.
During the hospital stay electrocardiograms were recorded
daily. Routine enzyme measurements were performed up to
12 h after the procedure and on recurrence of symptoms
thereafter. Patients with suspected ischemia underwent repeat
coronary angiography. Patients were followed as outpatients or
contacted by phone 1 month after the intervention.
Off-line quantitative angiographic analysis was carried out
using a validated automated edge detection software (CMS,
Medics Medical Imaging Systems, Nuenen, The Netherlands)
(31,32) by operators unaware of procedural and clinical out-
come of the patient.
The complexity of target lesions was assessed using the
modified American College of Cardiology/American Heart
Association scoring system (33). Complex lesions were defined
as lesions of type B2 or C. Left ventricular function was
assessed qualitatively; the diagnosis of reduced left ventricular
function required the presence of hypokinesia in at least one or
two segments. Procedural success was defined as placement of
the stent at the desired position with less than 30% residual
stenosis. Clinical events were recorded continuously. All
deaths were considered due to cardiac causes unless an
autopsy established a noncardiac cause. The diagnosis of acute
myocardial infarction was based on typical chest pain lasting
more than 30 min, abnormal Q waves not present on the
baseline electrocardiogram, or an increase in the creatine
kinase concentration to twice the upper limit of normal. The
diagnosis of recurrent myocardial infarction was also based on
an increase of more than 30% in the serum level of creatine
kinase. All CABGs, emergent or nonemergent, carried out in
the first 30 days and involving the stented vessel were also
recorded as cardiac events.
The primary end point of the study was the clinical outcome
of patients at 30 days after the procedure. A combined end
point of cardiac death, myocardial infarction and CABG was
defined as the clinical outcome measure. This was also the
most frequent end point used in similar studies with PTCA.
Operator experience was defined in two ways: the overall
number of interventions performed by an operator up to the
day of the actual procedure, and the yearly number of inter-
ventions. The secondary end point of the study was procedural
failure.
Statistical analysis. For the purpose of this study, the
lesion responsible for the adverse outcome (failed procedure,
subacute occlusion) or one lesion at random was selected for
analysis in patients with multilesion interventions. Continuous
variables are expressed as mean 6 standard deviation (SD).
Descriptive monovariate analysis for continuous data was
made using two-sided unpaired t-test. No attempt was made to
control for potential deviations from normal distribution since
the main analysis consisted in multivariate methods. Discrete
variables were analyzed using chi-square test with Yate’s
correction if appropriate. Operator experience, both as overall
and as yearly volume of procedures, was analyzed as a contin-
uous and ordinal variable as well. Since there are no previous
studies on this subject to offer meaningful cutoff points for
operator experience, transformation in an ordinal form was
performed by subdividing in volume ranges defined by the 20th
percentiles.
Multivariate analysis was based on multiple logistic regres-
sion models. The predictive accuracy of the model was assessed
by means of the area under receiver operating characteristic
(ROC) curve. Bootstrapping with 1,000 replications of the
original sample data was used for model validation and the
slope shrinkage parameter between training and test samples
was assessed (34). The primary end point of the study was
analyzed in three steps. First, a multiple logistic model was
built with baseline clinical and lesion characteristics. Using the
logistic regression equation, the expected rate for an adverse
outcome was obtained for each volume range. Next, the
risk-adjusted rate for a volume range was calculated as the
ratio between the observed and expected rate, multiplied by
the overall rate for the outcome in the entire study population.
The 95% confidence intervals (CI) for this risk-adjusted rate
were obtained, as previously described (35). In a second step,
operator experience was entered into the multiple logistic
regression model and tested for independent effect on the
outcome. Finally, independent predictors of an adverse out-
come were entered in a classification and regression tree
(CART) analysis to allow for risk stratification based on
baseline characteristics and indices of experience. In all three
steps, analyses were repeated for both measures of operator
experience and overall and yearly volume of procedures.
Multiple logistic regression analysis was also applied for as-
sessing the secondary end point of procedural failure. For all
Abbreviations and Acronyms
CABG 5 aortocoronary bypass surgery
CART 5 classification and regression tree analysis
PTCA 5 percutaneous transluminal coronary angioplasty
ROC 5 receiver operating characteristic curve
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statistical analyses the S-Plus Version 4 software (Mathsoft,
Inc., Seattle, WA) was used. Statistical significance was defined
as p values ,0.05.
Results
Primary end point analysis. All interventions described in
this study were performed by 10 operators. The number of
operators that contributed to each total volume quintile was
10, 9, 6, 4 and 3 for the 1°, 2°, 3°, 4° and 5° quintile, respectively.
The composite end point of cardiac death, nonfatal myocardial
infarction or CABG during the first 30 days after the proce-
dure was reached by 102 patients (2.99%). More specifically,
38 patients (1.1%) died of cardiac causes, 40 patients (1.2%)
sustained nonfatal myocardial infarction and 24 (0.7%) under-
went a successful CABG. During the same period one more
death occurred due to massive organ bleeding under antico-
agulation therapy. The cause of death was verified at autopsy.
The event rates for the different volume ranges were 2.97%,
3.82%, 3.50%, 3.08% and 1.60% in the 1°, 2°, 3°, 4° and 5°
quintiles, respectively. Demographic, clinical, angiographic
and operator volume data of the study population divided
according to the occurrence or nonoccurrence of cardiac
events are presented in Table 1. In addition, because almost all
stent placement procedures involved crimping stents onto the
balloon by hand, a separate analysis was made for the event of
stent loss. Sixty-three out of a total of 5,833 stents were lost
either in a peripheral artery (55 stents) or in the coronary
circulation (8 stents). The incidence of this event was 1.1% in
patients without adverse clinical outcome and 1.0% in those
with adverse clinical outcome (p 5 0.8). All demographic,
clinical and lesion-related variables listed in Table 1 were
entered into the multivariate model. Unstable angina, reduced
left ventricular function and complex lesions were associated
with higher probability of an adverse outcome. Figure 1
presents the risk-adjusted cardiac event rates and their 95%
CIs for the different volume ranges (quintiles), with the overall
observed rate as reference. Only the highest quintile corre-
sponding to a volume range of more than 483 stent implanta-
tions with the contribution of 3 operators presents a risk-
adjusted rate of 1.70% 6 1.28% that is significantly lower than
the reference level (p , 0.05). The rates for the lower four
quintiles of operator volume are at or above the overall rate.
Logistic regression analysis was repeated including operator
volume as an additional independent variable. The area under
the ROC curve for the model was 0.71. Figure 2 presents the
odds ratios (OR) of the independent correlates of the com-
posite end point. The most potent risk factor were complex
lesions with an OR of 2.91 (95% CIs, 1.48 to 5.71), followed by
unstable angina (2.0 [1.25 to 3.22]) and reduced left ventricular
function (1.62 [1.07 to 2.47]). Greater operator experience was
associated with a decreased risk: a volume of 500 procedures
presented an OR of 0.64 (0.43 to 0.96) with respect to a volume
of 100 procedures. The independent predictors derived from
the multiple logistic regression model were entered into a
CART analysis (Fig. 3). This analysis demonstrates that while
an experience of 100 or more procedures is sufficient for a
significant decrease in the risk of adverse outcome in patients
with simple lesions, much more experience (450 procedures or
more) is needed to improve the outcome of patients with
complex lesions.
The same type of analyses was carried out for the relation-
ship between the operator yearly volume of procedures and
Table 1. Characteristics of the Study Population According to the
Clinical Outcome of the Patients
Adverse
Outcome
(n 5 102)
No Adverse
Outcome
(n 5 3307) p
Age (yr) 64.7 6 11.9 62.7 6 10.9 0.060
Women 26.5 23.0 0.414
Arterial hypertension 56.9 58.7 0.716
Diabetes 20.6 14.0 0.060
Smoking 33.3 31.8 0.735
Hypercholesterolemia 32.4 37.7 0.271
Acute myocardial infarction 21.6 17.5 0.289
Unstable angina 52.0 39.2 0.009
Reduced left ventricular function 58.8 43.8 0.002
Multivessel disease 69.6 70.0 0.926
Target vessels 0.134
Left main 2.0 1.6
LAD 32.4 41.4
LCx 22.5 18.7
RCA 32.4 32.6
Venous bypass graft 10.8 5.8
Complex lesions 90.2 72.9 , 0.001
Diameter stenosis (%) 78.9 6 15.3 76.7 6 15.6 0.152
Vessel size (mm) 3.05 6 0.52 3.06 6 0.54 0.857
Lesion length (mm) 11.3 6 6.3 10.9 6 5.8 0.514
Operator volume 241 6 195 292 6 234 0.030
Operator yearly volume 135 6 82 152 6 77 0.027
Procedural failure 31.4 1.2 , 0.001
Data are percentages or mean 6 SD. LAD 5 left anterior descending
coronary artery; LCx 5 left circumflex coronary artery; RCA 5 right coronary
artery.
Figure 1. Plot of the risk-adjusted cardiac event rate (death, myocar-
dial infarction or bypass surgery) for different operator volume ranges
of stent placement procedures. Data presented as means and 95%
confidence intervals. Dotted line shows the event rate for the entire
population (2.99%).
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outcome. The number of operators that contributed to each
yearly volume quintile was 10, 7, 4, 3 and 2 for the 1°, 2°, 3°, 4°
and 5° quintile, respectively. The event rates for the different
yearly volume ranges were 4.44%, 2.91%, 2.72%, 1.94% and
2.79% in the 1°, 2°, 3°, 4° and 5° quintiles, respectively. Figure
4 shows that risk-adjusted event rate of 4.59% 6 1.17% for the
yearly volume range of ,90 procedures is significantly higher
than the overall event rate of 2.99% (p , 0.05). All operators
contributed to this quintile. The risk-adjusted rates for the
other higher quintiles are at or under the reference level.
Yearly volume of procedures resulted also in an independent
determinant of outcome in logistic regression analysis in
addition to lesion complexity, unstable angina and reduced left
ventricular function. A yearly volume of 140 procedures was
associated with an OR of 0.63 (0.44 to 0.89) as compared with
a volume of 70 procedures/year. The area under the ROC
curve for the model was 0.71. The CART analysis (Fig. 5)
indicates that a yearly volume of 70 procedures or more is
necessary to ensure a better outcome for both simple and
complex lesions.
Secondary end point analysis. Stent placement attempt
failed in 71 procedures (2.08%). In 45.1% of these patients,
procedural failure was complicated by an adverse outcome (vs.
2.1% for patients with successful procedures). The most fre-
quent reason for failure was the inability to reach the target
lesion with stent (79% of the cases). The observed failure rate
in the five volume ranges followed the same trend as the
cardiac event rate with 2.4%, 1.9%, 2.8%, 2.2% and 1.2% in
the 1°, 2°, 3°, 4° and 5° quintile, respectively. Table 2 presents
the univariate analysis of the patients’ characteristics according
to the procedural outcome. The multiple logistic model for
procedural failure demonstrated that complex lesions (p 5
0.007), small vessel size (p 5 0.028) and low operator volume
(p 5 0.032) were the only independent risk factors.
Figure 2. Graph presenting odds ratios and their 95% confidence
intervals for independent risk factors for an adverse outcome as
identified by multivariate analysis. For operator volume of stenting
procedures, the comparison is between 500 and 100 procedures. Odds
ratios are displayed on a logarithmic scale.
Figure 3. Graph presenting the CART model con-
structed with the independent risk factors for an
adverse outcome. The area of a circle is proportional
to the size of the subgroup. Numbers within the circles
indicate adverse outcome rate in percent for the given
subdivision. The analysis identifies at each level two
subgroups with a statistically significant difference in
adverse outcome rate. The number of operators that
contributed to procedures corresponding to the seven
terminal nodes of the CART was 8, 9, 10, 3, 3, 10 and
10, respectively (from the left to the right). Pts 5
patients; Proc. 5 procedures; LV Func. 5 left ventric-
ular function. Note the effect of operator volume of
stenting procedures on the outcome of patients.
Figure 4. Plot of the risk-adjusted cardiac event rate (death, myocar-
dial infarction or bypass surgery) for different operator yearly volume
ranges of stent placement procedures. Data presented as means and
95% confidence intervals. Dotted line presents the event rate for the
entire population (2.99%).
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Discussion
This study found a direct relationship between operator
experience in performing coronary stent placement and the
clinical outcome of the patients after this intervention. In
addition, we demonstrated that a risk-stratification protocol,
based on baseline clinical and angiographic characteristics, is
possible for patients undergoing coronary stent implantation.
This protocol helps in matching patient risk profile with the
minimal operator experience required to achieve acceptable
results.
Methodological issues. The primary end point of the study
was the clinical outcome of patients at 30 days after stent
placement procedure. The time frame for the end point
assessment was therefore 30 days, far beyond the hospital stay
period which is the usual interval of similar studies with PTCA
(3,5–9,36,37). Extension of the observation period has recently
been advocated for outcome studies after PTCA (38). This
may be particularly important for stent implantation where
thrombotic vessel occlusion, the most frequent cause of an
adverse clinical outcome, may also occur after the first week
(39). Therefore, the assessment of 30-day outcome reduces the
risk of missing major adverse events after the intervention.
Adopting the composite end point of death, myocardial infarc-
tion and CABG as the principal outcome measure, we ren-
dered our results comparable with most of the previous PTCA
studies (4–6,8). Due to the subjective nature of the definition
of procedural failure (30), it was used only as a secondary end
point in this study. The baseline characteristics of the patients
were taken into consideration specifically since the complex
interrelation between operator experience and the risk profile
of the patient undergoing the intervention has been recognized
(14). The only way to assess the individual skills of the operator
is to assess outcomes after adjusting for the influence of other
risk factors. The results of the present study are further
strengthened by the fact that we included in the multivariate
analysis not only the conventional patient and lesion charac-
teristics as others have done previously (6,8), but also lesion-
related quantitative variables. With current digital angio-
graphic equipment, these data are readily available to most of
the operators during the examination.
Comparison with previous findings for PTCA. This study
concurs with previous reports for PTCA (37,40–44) in finding
that baseline patient and lesion characteristics are the major
determinants of outcome after stent implantation procedure.
Not unexpectedly, complex lesions, unstable angina and re-
duced left ventricular function were associated with more
adverse events during the first 30 days. Although weaker than
the abovementioned factors, operator experience showed a
significant independent role in the patient outcome. Both
measures of operator experience and overall caseload and
yearly volume of procedures were correlated with a better
outcome. Our analysis indicated that a clear effect is achieved
with more than 480 procedures, which corresponds to the
highest quintile and with a yearly volume of more than 90
procedures. These relatively high levels may be explained by
the characteristics of our population. More than 70% of the
Table 2. Characteristics of the Study Population According to the
Procedural Outcome of the Patients
Failed
Procedures
(n 5 71)
Successful
Procedures
(n 5 3338) p
Age (yr) 64.2 6 11.9 62.7 6 10.9 0.271
Women 25.4 23.1 0.651
Arterial hypertension 53.5 58.7 0.379
Diabetes 14.1 14.2 0.984
Smoking 29.6 31.9 0.685
Hypercholesterolemia 28.2 37.8 0.100
Acute myocardial infarction 19.7 17.6 0.641
Unstable angina 38.0 39.6 0.784
Reduced left ventricular function 43.7 44.2 0.926
Multivessel disease 56.3 70.3 0.011
Target vessels 0.483
Left main 1.4 1.6
LAD 33.8 41.3
LCx 25.4 18.6
RCA 31.0 32.7
Venous bypass graft 8.5 5.9
Complex lesions 90.1 73.0 0.001
Diameter stenosis (%) 80.9 6 15.3 76.7 6 15.6 0.021
Vessel size (mm) 2.94 6 0.52 3.06 6 0.54 0.051
Lesion length (mm) 11.9 6 6.7 10.9 6 5.8 0.159
Operator volume 242 6 181 292 6 234 0.073
Operator yearly volume 131 6 83 152 6 77 0.025
Adverse outcome rate 45.1 2.1 , 0.001
Data are percentages or mean 6 SD. Abbreviations as in Table 1.
Figure 5. Graph presenting the CART model constructed with the
independent risk factors for cardiac events. The area of a circle is
proportional to the size of the subgroup. Numbers within the circles
indicate adverse outcome rate in percent for the given subdivision. The
analysis identifies at each level two subgroups with a statistically
significant difference in adverse outcome rate. The number of opera-
tors that contributed to procedures corresponding to the six terminal
nodes of the CART was 9, 9, 10, 9, 9 and 9, respectively (from the left
to the right). Pts 5 patients; Proc./Y 5 procedures per year; LV Func.
5 left ventricular function. Note the effect of operator yearly volume
of stenting procedures on the outcome of patients.
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lesions were complex and almost half of them of type C. The
CART analysis confirmed also that much more experience is
needed to achieve a better outcome in patients with complex
lesions.
Very useful information is provided by our CART analysis
based on patient and lesion characteristic in addition to
operator experience measures. The risk for an adverse out-
come showed a clear difference between complex and simple
lesions and, within either group, operator experience was the
most powerful predictor of outcome. This analysis showed that
even for patients with simple lesions, the operator should have
performed a minimum number of 100 procedures to ensure
acceptable results. This number coincides with that of 125
procedures recommended by the American College of Cardi-
ology and American Heart Association as the standard to be
met to achieve clinical competence during training in perform-
ing PTCA (18,19). In addition, our CART analysis demon-
strated that a minimum of 70 stenting procedures per year
need to be carried out to maintain good performance even for
patients with complex lesions. This figure is not different from
that of 75 procedures per year recommended by the American
College of Cardiology and American Heart Association to
maintain competency in PTCA (18,19). In summary, until
more definitive data are provided, the current guidelines for
PTCA (18,19) should be considered valid for coronary stent
placement as well. This study also suggests that the fulfillment
of the abovementioned experience criteria may be considered
only as a first step in the policy of improving the outcome of
patients undergoing coronary stent placement. To facilitate
achieving this goal, the risk profile of the patient should be
matched with adequate experience, reserving more experi-
enced operators for more complex lesions. Obviously, not all
characteristics of B2- or C-type lesions impart the same risk to
stent placement procedure. Our data in this regard constitute
only the first steps toward the definition of a complete strategy
that appropriately matches the patient’s risk with the interven-
tionalist’s experience.
Limitations. Coronary stenting has been associated with
the reduction of cardiac events as compared to PTCA (21,22).
This remarkable advantage brings about a paradoxical side
effect: the low number of events increases the risk for the
clinical investigation to be underpowered (12,30,45). Our study
is also affected by this risk. To overcome this pitfall, the use of
outcome at 6 months with much more events has been
advocated for interprovider comparison (38). Before adopting
such an end point a logical link should be demonstrated
between long-term outcome and operator experience. Thus,
larger scale investigations are needed in the future to confirm
the validity of the relationship found in this study. It has been
recognized, however, that despite their imperfections, the
statistical models are equal to or better than expert clinicians
in predicting patient outcome (30).
Coronary stenting may be considered an immature technol-
ogy. The superiority of combined antiplatelet therapy in com-
parison to older anticoagulation schemes has already been
demonstrated (23,46). Further improvements in poststenting
treatment are currently sought in therapies aiming at the
platelet fibrinogen receptor blockade (47) or in stent-coating
techniques (48). A yet to be proven role has been advocated
for high balloon pressure and intravascular ultrasound guid-
ance (49,50). A variety of stent designs is available on the
market. Because it has yet to be determined how these evolving
concepts and techniques affect clinical outcomes, Lindsay et al.
(38) recommended that comparisons must be made to concur-
rent experience. Another difficulty in including such variables
in the analysis comes from the close association between
adverse outcome and procedural failure in our study: 45.1% of
failures ended with an adverse event. The reason for failure in
the overwhelming majority of cases in this study was the
inability to reach the target lesion with stent before any of the
abovementioned changes could have been applied. Similar
difficulties have also prevented the studies of outcome after
PTCA (3,4,7–9) from including in the analysis advances in
guiding catheters, guiding wires or balloon catheters which
have certainly had a role in improving procedural results.
Finally, health care carriers are interested to know not only
the individual but also the institutional providers with better
outcomes after coronary interventions. The latter issue can not
be answered by the present study based on a single-center
experience. With the current widespread use of coronary stent
placement, time has come for undertaking multicenter studies
to address the relationship between institution volume of
procedures and outcome after stenting.
Conclusions. This study demonstrated that parallel to
other patient and lesion characteristics, operator experience
exerts an independent influence on the outcome of patients
undergoing coronary stent placement. These results suggest
that the current guidelines of the American College of Cardi-
ology and the American Heart Association for achieving and
maintaining competency in PTCA, that is, 125 procedures
performed during the training period and 75 procedures
performed annually, are also valid criteria for coronary stent
placement. In addition, the findings of this study may help to
identify patient’s risk before the intervention and appropriately
match it with the operator experience required for achieving
the most favorable outcome.
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